Eleven point four percent of adults aged 65 to 79 years with stage 1 hypertension would not be eligible under 2025 criteria.
Expanding coverage, lowering costs, and age-specific therapy models—MoodRx is redefining how Pennsylvanians access ...
Evolving Landscape of Parenteral Anticancer Therapy–Associated Lung Toxicity: Incidence, Monitoring, and Management This scoping review was conducted based on the Arksey and O'Malley framework and the ...
NEW ORLEANS – Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to ...
Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...
Adults can have ADHD, often undiagnosed since childhood. Dr. Dania Antalaya explains symptoms, how adult diagnosis works, and treatment options that can help. Thom Tillis wants you to know something: ...
CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast), taken as oral tablets, as a treatment for adults with progressive pulmonary fibrosis (PPF), in which lung scarring ...
These findings have been verified in adult animals of different species. A new mouse study from neuroscientists at MIT's Picower Institute shows that briefly and reversibly anesthetizing the retina of ...
What Is Uplizna, and Why Does It Matter? Uplizna (inebilizumab-cdon) is a prescription medicine recently approved by the FDA to treat adults with generalized myasthenia gravis (gMG) who test positive ...
The National Institute for Health and Care Excellence (NICE) has recommended obecabtagene autoleucel (obe-cel) for adults aged 26 and older with relapsed or refractory B-cell precursor acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results